Lactated Ringer’s Injection Recalled

On Aug. 19, 2026, B. Braun Medical Inc. initiated a voluntary recall of Excel^® Lactated Ringers injection, 1000mL and the FDA classified it as a Class I recall on Sept. 2, 2026. The recall was prompted by the presence of particulate matter in the solution, identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene. If infused intravenously, these particles may lead to clinically significant adverse outcomes, including pulmonary emboli, vascular occlusions that may result in tissue death or organ damage, phlebitis, immune system activation, organ dysfunction and hemolysis. Lactated Ringer's injection is FDA-approved for use as a source of water and electrolytes for hydration and fluid replacement. For more information, see here.